| |
| |
|
| Insider
Information: |
Dubovsky Filip |
| Relationship: |
President, R&D |
| City: |
Gaithersburg |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
66,613 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$23,947 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
66,613 |
|
|
| Total
Value |
$23,947 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Novavax Inc |
NVAX |
President, R&D |
2024-03-10 |
66,613 |
2023-06-16 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
13 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2024-03-10 |
4 |
D |
$5.45 |
$14,154 |
D/D |
(2,597) |
66,613 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2024-03-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,376 |
69,210 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2024-03-07 |
4 |
D |
$5.61 |
$52,689 |
D/D |
(9,392) |
63,834 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2024-03-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,444 |
73,226 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2023-12-14 |
4 |
D |
$5.69 |
$7,784 |
D/D |
(1,368) |
53,782 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2023-12-14 |
4 |
OE |
$5.69 |
$16,120 |
D/D |
2,833 |
55,150 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2023-11-05 |
4 |
D |
$7.06 |
$4,780 |
D/D |
(677) |
52,317 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2023-11-05 |
4 |
OE |
$7.06 |
$9,884 |
D/D |
1,400 |
52,994 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2023-09-16 |
4 |
D |
$7.71 |
$47,093 |
D/D |
(6,108) |
51,594 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2023-09-16 |
4 |
OE |
$7.71 |
$97,485 |
D/D |
12,644 |
57,702 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&DOfficer |
• – – |
2023-06-16 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
42,910 |
|
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2023-06-16 |
4 |
D |
$8.04 |
$16,136 |
D/D |
(2,007) |
45,058 |
0 |
- |
|
| NVAX |
Novavax Inc |
President, R&D |
• – – |
2023-06-16 |
4 |
OE |
$8.04 |
$33,406 |
D/D |
4,155 |
47,065 |
0 |
- |
|
13 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
